FDESX
Price
$35.75
Change
-$0.02 (-0.06%)
Updated
Jun 18 closing price
Net Assets
3.47B
RGAHX
Price
$77.44
Change
+$0.02 (+0.03%)
Updated
Jun 18 closing price
Net Assets
306.91B
Interact to see
Advertisement

FDESX vs RGAHX

Header iconFDESX vs RGAHX Comparison
Open Charts FDESX vs RGAHXBanner chart's image
Fidelity Advisor Diversified Stock O
Price$35.75
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets3.47B
American Funds Growth Fund of Amer R5E
Price$77.44
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets306.91B
FDESX vs RGAHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FDESX vs. RGAHX commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDESX is a Buy and RGAHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 307B vs. FDESX (3.47B). FDESX (0.51) and RGAHX (0.50) have matching dividends . FDESX was incepted earlier than RGAHX: FDESX (55 years) vs RGAHX (10 years). RGAHX (0.44) is less costly to investors than FDESX (0.41). FDESX is a more actively managed with annual turnover of: 84.00 vs. RGAHX (25.00). FDESX has a lower initial minimum investment than RGAHX: FDESX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 6.67 vs. FDESX (-6.60). RGAHX return over 5 years is better than : 45.35 vs. FDESX (34.05).
FDESXRGAHXFDESX / RGAHX
Total Expense Ratio0.410.4493%
Annual Report Gross Expense Ratio0.410.4493%
Fund Existence55 years10 years-
Gain YTD-0.1955.447-4%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.47B307B1%
Annual Yield % from dividends0.510.50101%
Returns for 1 year-6.606.67-99%
Returns for 3 years33.8856.4860%
Returns for 5 years34.0545.3575%
Returns for 10 years54.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENLV1.040.01
+1.46%
Enlivex Therapeutics Ltd
NTLA9.600.02
+0.21%
Intellia Therapeutics
DFH22.100.03
+0.14%
Dream Finders Homes
BIIB126.54-0.02
-0.02%
Biogen
CTRN29.23-0.55
-1.85%
Citi Trends